1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one

C139H149N19O19 — CID 161286133

IUPAC1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one
SMILESC/N=C1/C(=C2Cc3ccccc3N2)C(=O)[C@@H](C)N1c1cc(OC)cc(OC)c1.C/N=C1/C(=C2Cc3ccccc3N2)C(=O)[C@H](C)N1c1cc(OC)cc(OC)c1.COc1cc(OC)cc(N2C(N3CCCC3)=C(C3=Nc4ccccc4C3)C(=O)C2(C)C)c1.[H]/N=C1/C(=C2Cc3ccccc3N2)C(=O)C(C)(C)N1c1cc(OC([2H])([2H])[2H])cc(OC([2H])([2H])C)c1.[H]/N=C1/C(=C2Cc3ccccc3N2)C(=O)C(C)(CO)N1c1cc(OC)cc(OC)c1.[H]/N=C1/C(c2nc3ccccc3n2CC=C)=C(O)C(C)(C)N1c1cc(OC)cc(OC)c1
InChIInChI=1S/C26H29N3O3.C24H26N4O3.C23H25N3O3.C22H23N3O4.2C22H23N3O3/c1-26(2)24(30)23(22-13-17-9-5-6-10-21(17)27-22)25(28-11-7-8-12-28)29(26)18-14-19(31-3)16-20(15-18)32-4;1-6-11-27-19-10-8-7-9-18(19)26-23(27)20-21(29)24(2,3)28(22(20)25)15-12-16(30-4)14-17(13-15)31-5;1-5-29-17-12-15(11-16(13-17)28-4)26-22(24)20(21(27)23(26,2)3)19-10-14-8-6-7-9-18(14)25-19;1-22(12-26)20(27)19(18-8-13-6-4-5-7-17(13)24-18)21(23)25(22)14-9-15(28-2)11-16(10-14)29-3;2*1-13-21(26)20(19-9-14-7-5-6-8-18(14)24-19)22(23-2)25(13)15-10-16(27-3)12-17(11-15)28-4/h5-6,9-10,14-16H,7-8,11-13H2,1-4H3;6-10,12-14,25,29H,1,11H2,2-5H3;6-9,11-13,24-25H,5,10H2,1-4H3;4-7,9-11,23-24,26H,8,12H2,1-3H3;2*5-8,10-13,24H,9H2,1-4H3/b;25-22-;20-19?,24-22-;19-18?,23-21-;2*20-19?,23-22-/t;;;;2*13-/m....10/s1/i;;4D3,5D2;;;
InChIKeyRCALXKJSFNKHRR-JJLVKYOYSA-N
MW2394.87 g/mol
LogP23.06
Rot. Bonds26

About 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one

1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one (PubChem CID 161286133) has the molecular formula C139H149N19O19 and a molecular weight of 2394.87 g/mol. Its IUPAC name is 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one.

Molecular Properties

Compound Name1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one
PubChem CID161286133
Molecular FormulaC139H149N19O19
Molecular Weight2394.87 g/mol
Exact Mass2393.16
IUPAC Name1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one
SMILESC/N=C1/C(=C2Cc3ccccc3N2)C(=O)[C@@H](C)N1c1cc(OC)cc(OC)c1.C/N=C1/C(=C2Cc3ccccc3N2)C(=O)[C@H](C)N1c1cc(OC)cc(OC)c1.COc1cc(OC)cc(N2C(N3CCCC3)=C(C3=Nc4ccccc4C3)C(=O)C2(C)C)c1.[H]/N=C1/C(=C2Cc3ccccc3N2)C(=O)C(C)(C)N1c1cc(OC([2H])([2H])[2H])cc(OC([2H])([2H])C)c1.[H]/N=C1/C(=C2Cc3ccccc3N2)C(=O)C(C)(CO)N1c1cc(OC)cc(OC)c1.[H]/N=C1/C(c2nc3ccccc3n2CC=C)=C(O)C(C)(C)N1c1cc(OC)cc(OC)c1
InChIInChI=1S/C26H29N3O3.C24H26N4O3.C23H25N3O3.C22H23N3O4.2C22H23N3O3/c1-26(2)24(30)23(22-13-17-9-5-6-10-21(17)27-22)25(28-11-7-8-12-28)29(26)18-14-19(31-3)16-20(15-18)32-4;1-6-11-27-19-10-8-7-9-18(19)26-23(27)20-21(29)24(2,3)28(22(20)25)15-12-16(30-4)14-17(13-15)31-5;1-5-29-17-12-15(11-16(13-17)28-4)26-22(24)20(21(27)23(26,2)3)19-10-14-8-6-7-9-18(14)25-19;1-22(12-26)20(27)19(18-8-13-6-4-5-7-17(13)24-18)21(23)25(22)14-9-15(28-2)11-16(10-14)29-3;2*1-13-21(26)20(19-9-14-7-5-6-8-18(14)24-19)22(23-2)25(13)15-10-16(27-3)12-17(11-15)28-4/h5-6,9-10,14-16H,7-8,11-13H2,1-4H3;6-10,12-14,25,29H,1,11H2,2-5H3;6-9,11-13,24-25H,5,10H2,1-4H3;4-7,9-11,23-24,26H,8,12H2,1-3H3;2*5-8,10-13,24H,9H2,1-4H3/b;25-22-;20-19?,24-22-;19-18?,23-21-;2*20-19?,23-22-/t;;;;2*13-/m....10/s1/i;;4D3,5D2;;;
InChIKeyRCALXKJSFNKHRR-JJLVKYOYSA-N
XLogP23.06
TPSA433.82 Ų
H-Bond Donors9
H-Bond Acceptors33
Rotatable Bonds26
Heavy Atoms177
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002394.87
LogP ≤ 523.06
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one?
The IUPAC name of 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one (CID 161286133) is 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one.
What is the SMILES notation for 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one?
The canonical SMILES for 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one is C/N=C1/C(=C2Cc3ccccc3N2)C(=O)[C@@H](C)N1c1cc(OC)cc(OC)c1.C/N=C1/C(=C2Cc3ccccc3N2)C(=O)[C@H](C)N1c1cc(OC)cc(OC)c1.COc1cc(OC)cc(N2C(N3CCCC3)=C(C3=Nc4ccccc4C3)C(=O)C2(C)C)c1.[H]/N=C1/C(=C2Cc3ccccc3N2)C(=O)C(C)(C)N1c1cc(OC([2H])([2H])[2H])cc(OC([2H])([2H])C)c1.[H]/N=C1/C(=C2Cc3ccccc3N2)C(=O)C(C)(CO)N1c1cc(OC)cc(OC)c1.[H]/N=C1/C(c2nc3ccccc3n2CC=C)=C(O)C(C)(C)N1c1cc(OC)cc(OC)c1.
What is the InChIKey of 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one?
The InChIKey is RCALXKJSFNKHRR-JJLVKYOYSA-N. The full InChI is InChI=1S/C26H29N3O3.C24H26N4O3.C23H25N3O3.C22H23N3O4.2C22H23N3O3/c1-26(2)24(30)23(22-13-17-9-5-6-10-21(17)27-22)25(28-11-7-8-12-28)29(26)18-14-19(31-3)16-20(15-18)32-4;1-6-11-27-19-10-8-7-9-18(19)26-23(27)20-21(29)24(2,3)28(22(20)25)15-12-16(30-4)14-17(13-15)31-5;1-5-29-17-12-15(11-16(13-17)28-4)26-22(24)20(21(27)23(26,2)3)19-10-14-8-6-7-9-18(14)25-19;1-22(12-26)20(27)19(18-8-13-6-4-5-7-17(13)24-18)21(23)25(22)14-9-15(28-2)11-16(10-14)29-3;2*1-13-21(26)20(19-9-14-7-5-6-8-18(14)24-19)22(23-2)25(13)15-10-16(27-3)12-17(11-15)28-4/h5-6,9-10,14-16H,7-8,11-13H2,1-4H3;6-10,12-14,25,29H,1,11H2,2-5H3;6-9,11-13,24-25H,5,10H2,1-4H3;4-7,9-11,23-24,26H,8,12H2,1-3H3;2*5-8,10-13,24H,9H2,1-4H3/b;25-22-;20-19?,24-22-;19-18?,23-21-;2*20-19?,23-22-/t;;;;2*13-/m....10/s1/i;;4D3,5D2;;;.
What are the key properties of 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one?
1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one has a molecular weight of 2394.87 g/mol, XLogP of 23.06, 26 rotatable bonds, 9 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(1,1-dideuterioethoxy)-5-(trideuteriomethoxy)phenyl]-4-(1,3-dihydroindol-2-ylidene)-5-imino-2,2-dimethylpyrrolidin-3-one;4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-imino-2-methylpyrrolidin-3-one;(2S)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;(2R)-4-(1,3-dihydroindol-2-ylidene)-1-(3,5-dimethoxyphenyl)-2-methyl-5-methyliminopyrrolidin-3-one;1-(3,5-dimethoxyphenyl)-5-imino-2,2-dimethyl-4-(1-prop-2-enylbenzimidazol-2-yl)pyrrol-3-ol;1-(3,5-dimethoxyphenyl)-4-(3H-indol-2-yl)-2,2-dimethyl-5-pyrrolidin-1-ylpyrrol-3-one is sourced from PubChem (CID 161286133), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).